Neurogenic insulin resistance in guinea-pigs with cisplatin-induced neuropathy

European Journal of Pharmacology

Volumn 531, Issue 1-3, 2006, Pages 217-225

  Szilvássy, Judit ^a   Sziklai, István ^a   Sári, Réka ^a   Németh, József ^b   Peitl, Barna ^a   Porszasz, Robert ^a   Lonovics, János ^c   Szilvássy, Zoltán ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cisplatin; Insulin resistance; Sensory neuropathy

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE[8-37]; CAPSAICIN; CISPLATIN; INSULIN SENSITIZING AGENT; N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENERVATION; DESENSITIZATION; DRUG INDUCED DISEASE; DRUG SENSITIZATION; GASTROCNEMIUS MUSCLE; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GUINEA PIG; HEART MUSCLE; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NEUROLOGIC DISEASE; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; ANTINEOPLASTIC AGENTS; ATROPINE; BLOOD GLUCOSE; BODY WEIGHT; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CELIAC PLEXUS; CISPLATIN; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUCOSE CLAMP TECHNIQUE; GUINEA PIGS; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENTS; PERIPHERAL NERVOUS SYSTEM DISEASES; VASODILATOR AGENTS;

EID: 32044455760     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.018     Document Type: Article

References (41)

1. A. Bajza, B. Peitl, J. Nemeth, R. Porszasz, G. Rabloczky, P. Literati-Nagy, J. Szilvassy, and Z. Szilvassy Development of insulin resistance by nitrate tolerance in conscious rabbits J. Cardiovasc. Pharmacol. 43 2004 471 476
2. I. Barajon, M. Bersani, M. Quartu, M. Del Fiacco, G. Cavaletti, J.J. Holst, and G. Tredici Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy Exp. Neurol. 138 1996 93 104
3. I. Benko, K. Djazayeri, C. Abraham, J. Zsuga, and Z. Szilvassy Rosiglitazone-induced protection against myelotoxicity produced by 5-fluorouracil Eur. J. Pharmacol. 477 2003 179 182
4. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
5. G. Cavaletti, D. Fabbrica, C. Minoia, L. Frattola, and G. Tredici Carboplatin toxic effects on the peripheral nervous system of the rat Ann. Oncol. 9 1998 443 447
6. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am. J. Physiol. 237 1979 E214 E223
7. N. Erin, F. Ercan, B.C. Yegen, S. Arbak, I. Okar, and S. Oktay Role of capsaicin-sensitive nerves in gastric and hepatic injury induced by cold-restraint stress Dig. Dis. Sci. 45 2000 1889 1899
8. P. Ferdinandy, T. Csont, C. Csonka, M. Torok, M. Dux, J. Nemeth, L.I. Horvath, L. Dux, Z. Szilvassy, and G. Jancso Capsaicin-sensitive local sensory innervation is involved in pacing-induced preconditioning in rat hearts: role of nitric oxide and CGRP? Naunyn-Schmiedeberg's Arch. Pharmacol. 356 1997 356 363
9. J.P. Fillastre, and G. Raguenez-Viotte Cisplatin nephrotoxicity Toxicol. Lett. 46 1989 163 175
10. W.H. Gispen, F.P. Hamers, C.J. Vecht, F.G. Jennekens, and J.P. Neyt ACTH/MSH like peptides in the treatment of cisplatin neuropathy J. Steroid Biochem. Mol. Biol. 43 1992 179 183
11. G. Jancso, E. Kiraly, and A. Jancso-Gabor Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones Nature 270 1977 741 743
12. W. Janig, and S.J. Lisney Small diameter myelinated afferents produce vasodilatation but not plasma extravasation in rat skin J. Physiol. 415 1989 477 486
13. S.J. Koopmans, B. Leighton, and R.A. DeFronzo Neonatal de-afferentation of capsaicin-sensitive sensory nerves increases in vivo insulin sensitivity in conscious adult rats Diabetologia 41 1998 813 820
14. W.W. Lautt The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes Can. J. Physiol. Pharm. 77 1999 553 562
15. W.W. Lautt Practice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: methods to quantitate mechanisms of insulin resistance Med. Res. Rev. 23 2003 1 14
16. W.W. Lautt A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis J. Pharmacol. Sci. 95 2004 9 17
17. W.W. Lautt, X. Wang, P. Sadri, D.J. Legare, and M.P. Macedo Rapid insulin sensitivity test (RIST) Can. J. Physiol. Pharm. 76 1998 1080 1086
18. W.W. Lautt, M.P. Macedo, P. Sadri, S. Takayama, R.F. Duarte, and D.J. Legare Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting Am. J. Physiol. Gasterointest. Liver Physiol. 281 2001 G29 G36
19. F.J. Miao, W. Janig, and J.D. Levine Vagal branches involved in inhibition of bradykinin-induced synovial plasma extravasation by intrathecal nicotine and noxious stimulation in the rat J. Physiol. 498 Pt 2 1997 473 481
20. M.C. Moore, S. Satake, B. Baranowski, P.S. Hsieh, D.W. Neal, and A.D. Cherrington Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs Am. J. Physiol. Endocrinol. Metab. 282 2002 E286 E296
21. J. Nemeth, Z. Szilvassy, M. Than, G. Oroszi, R. Sari, and J. Szolcsanyi Decreased sensory neuropeptide release from trachea of rats with streptozotocin-induced diabetes Eur. J. Pharmacol. 369 1999 221 224
22. J. Nemeth, M. Than, R. Sari, B. Peitl, G. Oroszi, B. Farkas, J. Szolcsanyi, and Z. Szilvassy Impairment of neurogenic inflammatory and anti-inflammatory responses in diabetic rats Eur. J. Pharmacol. 386 1999 83 88
23. R.F. Ozols, and R.C. Young High-dose cisplatin therapy in ovarian cancer Semin. Oncol. 12 1985 21 30
24. B. Peitl, G. Petho, R. Porszasz, J. Nemeth, and J. Szolcsanyi Capsaicin-insensitive sensory-efferent meningeal vasodilatation evoked by electrical stimulation of trigeminal nerve fibres in the rat Br. J. Pharmacol. 127 1999 457 467
25. P.W. Pisters, E. Cersosimo, A. Rogatko, and M.F. Brennan Insulin action on glucose and branched-chain amino acid metabolism in cancer cachexia: differential effects of insulin Surgery 111 1992 301 310
26. R. Porszasz, G. Legvari, J. Nemeth, P.N. Literati, J. Szolcsanyi, and Z. Szilvassy The sensory nitrergic nature of the hepatic insulin sensitizing substance mechanism in conscious rabbits Eur. J. Pharmacol. 443 2002 211 212
27. R. Porszasz, G. Legvari, T. Pataki, J. Szilvassy, J. Nemeth, P. Kovacs, G. Paragh, J. Szolcsanyi, and Z. Szilvassy Hepatic insulin sensitizing substance: a novel 'sensocrine' mechanism to increase insulin sensitivity in anaesthetized rats Br. J. Pharmacol. 139 2003 1171 1179
28. P. Sadri, and W.W. Lautt Blockade of hepatic nitric oxide synthase causes insulin resistance Am. J. Physiol. 277 1999 G101 G108
29. P. Sadri, D.J. Legare, and W.W. Lautt Insulin resistance caused by nitric oxide synthase inhibition Proc. West. Pharmacol. Soc. 40 1997 19 20
30. D.J. Stewart, S. Verma, and J.A. Maroun Phase I study of the combination of disulfiram with cisplatin Am. J. Clin. Oncol. 10 1987 517 519
31. J. Szilvassy, I. Sziklai, T. Racz, P. Horvath, G. Rabloczky, and Z. Szilvassy Impaired bronchomotor responses to field stimulation in guinea-pigs with cisplatin-induced neuropathy Eur. J. Pharmacol. 403 2000 259 265
32. J. Szilvassy, I. Sziklai, P. Horvath, M. Szilasi, J. Nemeth, P. Kovacs, and Z. Szilvassy Feeble bronchomotor responses in diabetic rats in association with decreased sensory neuropeptide release Am. J. Physiol., Lung Cell. Mol. Physiol. 282 2002 L1023 L1030
33. J. Szolcsanyi Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism Prog. Brain Res. 113 1996 343 359
34. J. Szolcsanyi, Z. Helyes, G. Oroszi, J. Nemeth, and E. Pinter Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve Br. J. Pharmacol. 123 1998 936 942
35. G. Tredici, G. Cavaletti, M.G. Petruccioli, D. Fabbrica, M. Tedeschi, and P. Venturino Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats Neurotoxicology 15 1994 701 704
36. S. Wallenstein, C.L. Zucker, and J.L. Fleiss Some statistical methods useful in circulation research Circ. Res. 47 1980 1 9
37. H. Xie, and W.W. Lautt Insulin resistance produced by hepatic denervation or muscarinic cholinergic blockade Proc. West. Pharmacol. Soc. 37 1994 39 40
38. H. Xie, and W.W. Lautt Induction of insulin resistance by cholinergic blockade with atropine in the cat J. Auton. Pharm. 15 1995 361 369
39. H. Xie, and W.W. Lautt Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration Am. J. Physiol. 271 1996 E587 E592
40. H. Xie, V.A. Tsybenko, M.V. Johnson, and W.W. Lautt Insulin resistance of glucose response produced by hepatic denervations Can. J. Physiol. Pharm. 71 1993 175 178
41. T. Yoshikawa, Y. Noguchi, C. Doi, T. Makino, and K. Nomura Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure Nutrition 17 2001 590 593